Philip Stern

Loughborough University

Professor

Loughborough, LE11 3TU

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

754

SSRN CITATIONS

0

CROSSREF CITATIONS

6

Scholarly Papers (3)

1.

Can Branded Drugs Benefit from Generic Entry? Switching to Non-Bioequivalent Molecules and the Role of Physician Response to Detailing and Prices

Number of pages: 44 Posted: 26 Jun 2007 Last Revised: 29 Jul 2012
IESE Business School, Barcelona, Spain, Imperial College London, Tanaka Business School, University of Southern California - Marshall School of Business and Loughborough University
Downloads 406 (72,214)

Abstract:

Loading...

Generic entry, Pharmaceuticals, Heterogeneity, Competition

2.

Physicians' Persistence and its Implications for Their Response to Promotion of Prescription Drugs

Management Science, 2007
Number of pages: 32 Posted: 25 Sep 2007
University of South Carolina - Darla Moore School of Business, University of Southern California - Marshall School of Business, Imperial College London, Tanaka Business School and Loughborough University
Downloads 293 (104,338)

Abstract:

Loading...

Pharmaceuticals, Physician decision making, State dependence, choice models

3.

Forecasting New Product Trial with Analogous Series

Number of pages: 17 Posted: 16 May 2011
Malcolm Wright and Philip Stern
Massey University - Department of Communication, Journalism & Marketing and Loughborough University
Downloads 55 (375,312)

Abstract:

Loading...

New Products, Consumer Trial, Penetration Growth, Analogous Series, Empirical Generalization Pharmaceuticals, Packaged Goods